Indicatrix is excited to announce that we have begun to search for next year’s undergraduate industrial placement student. Details can be found following the link below, and applications will be accepted until 4th Feb 2022
Industrial Placement Student
We’re excited to announce that this year we’ll be taking on an industrial placement student to work alongside our team through the academic year 2021/22. If you’d be interested in applying for the post then please see the attached job description.
A Pint of Science
Dr Mike Probert gave a talk highlighting the impacts of technologies operating at the nano-scale as part of the Pint of Science festival. Specifically he breaks down the benefits of ENaCt within the realms of pharmaceutical development.
ENaCt Development Continues with New PhD Research Project
The development of our ground breaking high-throughput Encapsulated Nanoscale Crystallization technology (ENaCt) will continue via a Newcastle University-based PhD CASE award with AstraZeneca. The aim of the project is to ‘control’ the solid form of new drug-like molecules to have improved bioavailability and physical properties.
More details can be found on the Newcastle University website:
https://www.ncl.ac.uk/postgraduate/funding/sources/allstudents/case2102.html?s=09
Accelerating Antibiotic Discovery
Indicatrix CEO Dr Michael Hall delivering a presentation on Encapsulated Nanodroplet Crystallisation experiments for the Winter 2020 ABX Antibiotic Discovery meeting held at the University of Plymouth. The talk covers the general concept of ENaCt as well as it’s development and features some nice examples which have been worked on by the team at Newcastle University.
ENaCt Referenced in the EPR
The impact of Indicatrix’s patent pending ENaCt technology on the potential enchantment of drug development pipelines is highlighted in a new article in the European Pharmaceutical Review “New Technique to Grow Crystals from Nanoscale Droplets Developed”.
New technique to grow crystals from nanoscale droplets developed (europeanpharmaceuticalreview.com)
Welcome Jake Weatherston!
Indicatrix Crystallography welcomes to our newest team member Jake Weatherston.
Jake joins Indicatrix as an industrial PhD student position, in collaboration with Newcastle University, supported by the Intensive Industrial Innovation Programme (IIIP) and the European Regional Development Fund.
With plenty of industrial experience from his time at High Force Research Ltd and an MChem degree from Newcastle University, Jake will bring his expertise to bear developing new methods and industrial applications for our break-through Encapsulated Nanodroplet Crystallisation (ENaCt) technology.
We look forward to doing lots of great science together with Jake over the coming years.
Indicatrix is Open for Business
Indicatrix Crystallography Ltd. has completed spin-out negotiations with Newcastle University and is now available for business. Contract small molecule crystallisation and single crystal X-ray analysis projects now available. Check out our Services page or our listings on Scientist.com and ScienceExchange.com.
Indicatrix shortlisted for RSC Emerging Technologies 2020
Indicatrix Crystallography is selected by the Royal Society of Chemistry (@RoySocChem) as one of 6 finalists in the Heath category for the prestigious Emerging Technologies Competition 2020.
https://www.rsc.org/competitions/emerging-technologies/2020-finalists-and-winners/
ENaCt technology highlighted in Pharma Technology Focus
The potential impact of our crystallisation technology in the pharmaceutical sector is discussed in an article in Pharma Technology Focus
HOW A NEW CRYSTALLOGRAPHY TECHNIQUE MAY SPEED UP DRUG DEVELOPMENT